HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

val-valacyclovir

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purinones: 2
        Hypoxanthines: 1
        Guanine: 1793
        Acyclovir: 4814
        Valacyclovir: 799
        val-valacyclovir: 2
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Branched-Chain Amino Acids: 2289
    - Valine: 1999
      - val-valacyclovir: 2
  - Essential Amino Acids: 1152
    - Valine: 1999
      - val-valacyclovir: 2

Experts

1.	Fujisawa, Masato: 2 articles (12/2007 - 06/2006)
2.	Gotoh, Akinobu: 2 articles (12/2007 - 06/2006)
3.	Hara, Isao: 2 articles (12/2007 - 06/2006)
4.	Hinata, Nobuyuki: 2 articles (12/2007 - 06/2006)
5.	Kamidono, Sadao: 2 articles (12/2007 - 06/2006)
6.	Shirakawa, Toshiro: 2 articles (12/2007 - 06/2006)
7.	Tanaka, Kazushi: 2 articles (12/2007 - 06/2006)
8.	Terao, Shuji: 2 articles (12/2007 - 06/2006)
9.	Chung, Leland W K: 1 article (12/2007)
10.	Fuji, Kohzo: 1 article (12/2007)

Related Diseases

1.

Prostatic Neoplasms (Prostate Cancer)

12/01/2007 - "We evaluated the long-term safety and efficacy of Ad-OC-TK (recombinant adenoviral vector carrying an osteocalcin promoter-driven herpes simplex virus thymidine kinase gene) plus VAL (valacyclovir) gene therapy for hormone-refractory prostate cancer. "
06/01/2006 - "Previously, Gardner and Chung conducted a phase I clinical trial of Ad-OC-TK (recombinant adenoviral vector containing osteocalcin promoter-driven herpes simplex virus thymidine kinase gene) plus VAL (valacyclovir) for the treatment of hormone-refractory prostate cancer at the University of Virginia. "

Related Drugs and Biologics

1.	Osteocalcin
2.	Thymidine Kinase
3.	Hormones (Hormone)